Charles Schwab Investment Management Inc. Has $85.66 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Charles Schwab Investment Management Inc. boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 0.5% in the third quarter, HoldingsChannel reports. The firm owned 1,175,061 shares of the company’s stock after buying an additional 6,184 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Henry Schein were worth $85,662,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Cromwell Holdings LLC boosted its position in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein during the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein in the second quarter worth approximately $37,000. Blue Trust Inc. grew its stake in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. Finally, Farther Finance Advisors LLC increased its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on HSIC. JPMorgan Chase & Co. cut their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Six equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $77.66 on Thursday. The business’s fifty day simple moving average is $71.15 and its 200 day simple moving average is $69.78. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The firm has a market capitalization of $9.68 billion, a P/E ratio of 31.96, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.32 EPS. As a group, analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.